Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

An ocular glymphatic clearance system removes β-amyloid from the rodent eye.

Wang X, Lou N, Eberhardt A, Yang Y, Kusk P, Xu Q, Förstera B, Peng S, Shi M, Ladrón-de-Guevara A, Delle C, Sigurdsson B, Xavier ALR, Ertürk A, Libby RT, Chen L, Thrane AS, Nedergaard M.

Sci Transl Med. 2020 Mar 25;12(536). pii: eaaw3210. doi: 10.1126/scitranslmed.aaw3210.

PMID:
32213628
2.

Meningeal Lymphangiogenesis and Enhanced Glymphatic Activity in Mice with Chronically Implanted EEG Electrodes.

Hauglund NL, Kusk P, Kornum BR, Nedergaard M.

J Neurosci. 2020 Mar 11;40(11):2371-2380. doi: 10.1523/JNEUROSCI.2223-19.2020. Epub 2020 Feb 11.

PMID:
32047056
3.

Targeted delivery of nerve growth factor to the cholinergic basal forebrain of Alzheimer's disease patients: application of a second-generation encapsulated cell biodelivery device.

Eyjolfsdottir H, Eriksdotter M, Linderoth B, Lind G, Juliusson B, Kusk P, Almkvist O, Andreasen N, Blennow K, Ferreira D, Westman E, Nennesmo I, Karami A, Darreh-Shori T, Kadir A, Nordberg A, Sundström E, Wahlund LO, Wall A, Wiberg M, Winblad B, Seiger Å, Wahlberg L, Almqvist P.

Alzheimers Res Ther. 2016 Jul 7;8(1):30. doi: 10.1186/s13195-016-0195-9.

4.

Encapsulated galanin-producing cells attenuate focal epileptic seizures in the hippocampus.

Nikitidou L, Torp M, Fjord-Larsen L, Kusk P, Wahlberg LU, Kokaia M.

Epilepsia. 2014 Jan;55(1):167-74. doi: 10.1111/epi.12470. Epub 2013 Nov 18.

5.

Targeted delivery of nerve growth factor via encapsulated cell biodelivery in Alzheimer disease: a technology platform for restorative neurosurgery.

Wahlberg LU, Lind G, Almqvist PM, Kusk P, Tornøe J, Juliusson B, Söderman M, Selldén E, Seiger Å, Eriksdotter-Jönhagen M, Linderoth B.

J Neurosurg. 2012 Aug;117(2):340-7. doi: 10.3171/2012.2.JNS11714. Epub 2012 Jun 1.

PMID:
22655593
6.

Increased encapsulated cell biodelivery of nerve growth factor in the brain by transposon-mediated gene transfer.

Fjord-Larsen L, Kusk P, Emerich DF, Thanos C, Torp M, Bintz B, Tornøe J, Johnsen AH, Wahlberg LU.

Gene Ther. 2012 Oct;19(10):1010-7. doi: 10.1038/gt.2011.178. Epub 2011 Nov 24.

PMID:
22113314
7.

Long-term delivery of nerve growth factor by encapsulated cell biodelivery in the Göttingen minipig basal forebrain.

Fjord-Larsen L, Kusk P, Tornøe J, Juliusson B, Torp M, Bjarkam CR, Nielsen MS, Handberg A, Sørensen JC, Wahlberg LU.

Mol Ther. 2010 Dec;18(12):2164-72. doi: 10.1038/mt.2010.154. Epub 2010 Jul 27.

8.

Generation and properties of a new human ventral mesencephalic neural stem cell line.

Villa A, Liste I, Courtois ET, Seiz EG, Ramos M, Meyer M, Juliusson B, Kusk P, Martínez-Serrano A.

Exp Cell Res. 2009 Jul 1;315(11):1860-74. doi: 10.1016/j.yexcr.2009.03.011. Epub 2009 Mar 24.

PMID:
19327351
9.

GDNF released from encapsulated cells suppresses seizure activity in the epileptic hippocampus.

Kanter-Schlifke I, Fjord-Larsen L, Kusk P, Angehagen M, Wahlberg L, Kokaia M.

Exp Neurol. 2009 Apr;216(2):413-9. doi: 10.1016/j.expneurol.2008.12.021. Epub 2009 Jan 7.

PMID:
19162016
10.

Efficient in vivo protection of nigral dopaminergic neurons by lentiviral gene transfer of a modified Neurturin construct.

Fjord-Larsen L, Johansen JL, Kusk P, Tornøe J, Grønborg M, Rosenblad C, Wahlberg LU.

Exp Neurol. 2005 Sep;195(1):49-60.

PMID:
15919076
11.

A new versatile and compact lentiviral vector.

Leander Johansen J, Dagø L, Tornøe J, Rosenblad C, Kusk P.

Mol Biotechnol. 2005 Jan;29(1):47-56.

PMID:
15668519
12.
13.
14.
15.

Purification and stabilization of transcriptionally active glucocorticoid receptor.

Warren BS, Kusk P, Wolford RG, Hager GL.

J Biol Chem. 1996 May 10;271(19):11434-40.

16.

Role of the TATA box in transcription of the mouse mammary tumor virus long terminal repeat.

Kusk P, Carlson KE, Warren BS, Hager GL.

Mol Endocrinol. 1995 Sep;9(9):1180-92.

PMID:
7491110
17.

Mapping of a new immunodominant human linear B-cell epitope on the vpu protein of the human immunodeficiency virus type 1.

Kusk P, Lindhardt BO, Bugge TH, Holmbäck K, Hulgaard EF.

J Acquir Immune Defic Syndr (1988). 1993 Apr;6(4):334-8.

PMID:
7681110
18.

Autologous antibody response against the principal neutralizing domain of human immunodeficiency virus type 1 isolated from infected humans.

Holmbäck K, Kusk P, Hulgaard EF, Bugge TH, Scheibel E, Lindhardt BO.

J Virol. 1993 Mar;67(3):1612-9.

19.

Mapping of two new human B-cell epitopes on HIV-1 gp120.

Kusk P, Holmbäck K, Lindhardt BO, Hulgaard EF, Bugge TH.

AIDS. 1992 Dec;6(12):1451-6.

PMID:
1283518
20.

Mapping of linear B-cell epitopes on the major core protein p24 of human immunodeficiency virus type 1 (HIV-1).

Kusk P, Bugge TH, Lindhardt BO, Hulgaard EF, Holmbäck K.

AIDS Res Hum Retroviruses. 1992 Oct;8(10):1789-94.

PMID:
1280956
21.

Competition ELISA using a human monoclonal antibody for detection of antibodies against human immunodeficiency virus type 1.

Bugge TH, Hansen LL, Lindhardt BO, Kvinesdal B, Kusk P, Holmbäck K, Hulgaard E, Ulrich K.

J Virol Methods. 1991 Apr;32(1):1-10.

PMID:
1712361
22.

Analysis of a highly immunodominant epitope in the human immunodeficiency virus type 1 transmembrane glycoprotein, gp41, defined by a human monoclonal antibody.

Bugge TH, Lindhardt BO, Hansen LL, Kusk P, Hulgaard E, Holmbäck K, Klasse PJ, Zeuthen J, Ulrich K.

J Virol. 1990 Sep;64(9):4123-9.

23.

Analysis of the secondary structure of the human immunodeficiency virus (HIV) proteins p17, gp120, and gp41 by computer modeling based on neural network methods.

Andreassen H, Bohr H, Bohr J, Brunak S, Bugge T, Cotterill RM, Jacobsen C, Kusk P, Lautrup B, Petersen SB, et al.

J Acquir Immune Defic Syndr (1988). 1990;3(6):615-22.

PMID:
2187072
24.

HIV neutralizing antibodies: development and association with HIV related disease.

Arendrup M, Ulrich K, Nielsen JO, Lindhardt BO, Kusk P, Mathiesen LR, Pedersen C, Krogsgaard K.

Scand J Infect Dis. 1989;21(1):19-26.

PMID:
2727625
25.

A comparison of three methods for detection of antibodies against the major core protein p24 of human immunodeficiency virus.

Lindhardt BO, Pedersen C, Ulrich K, Kusk P.

J Virol Methods. 1988 Dec;22(2-3):119-24.

PMID:
3146581
26.

Serological response in patients with chronic asymptomatic human immunodeficiency virus infection.

Lindhardt BO, Ulrich K, Kusk P, Hofmann B.

Eur J Clin Microbiol Infect Dis. 1988 Jun;7(3):394-9.

PMID:
2970386
27.

Immunological characterization and detection of the major core protein p24 of the human immunodeficiency virus (HIV) using monoclonal antibodies.

Kusk P, Ulrich K, Zeuthen J, Pallesen G.

J Acquir Immune Defic Syndr (1988). 1988;1(4):326-32.

PMID:
2464053

Supplemental Content

Support Center